Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Executed Iranian nuclear scientist confessed to aiding Israel after torture, threats against mother - 2I was about to film a movie with Glen Powell when my hair started falling out in clumps. Alopecia has made me unrecognizable as an actor.
- 3Most loved VR Game for Wellness: Which Keeps You Dynamic?
- 4Favored Chinese Dish: Make Your Determination
- 5From Fledgling to Master: Self-awareness in a Side interest
- Change Your Home into an Exercise center with These Famous Wellness Gadgets
- 6 Arranging Administrations to Change Your Open air Space
- The Advancement and Effect of Dental Embed Innovation on Oral Wellbeing
- The pace of hiring just fell to the lowest since 2011, outside of the pandemic
- Explosions at Burundi ammunition depot kill civilians, witnesses say
- What we know about Jonathan Ross, the ICE agent who shot and killed Renee Nicole Good in Minneapolis
- Want to read more in 2026? Here's how to revive your love of books
- Underestimated Metropolitan Experience Urban communities On the planet
- Finding the Universe of Workmanship: Individual Encounters in Imagination
